[1] O. S. Platt, D. T. Bruce, J. B. Donald, F. M. Paul, F. R. Wendell, V. Elliott and R. K. Thomas, “Pain in Sickle Cell Disease—Rates and Risk Factors,” The New England Journal of Medicine, Vol. 325, No. 1, 1991, 1991, pp. 11-16. doi:10.1056/NEJM199107043250103
[2] J. J. Field and M. R. DeBauen, “Acute Pain Management in Adults with Sickle Cell Disease,” 2012. http://medjournal.hmc.psu.edu:4219/contents/acute-pain-management-in-adults-with-sickle-cell-disease?source=search_result&search=sickle+cell+pain+management&selectedTitle = 1%7E150
[3] R. Dunlop and K. C. L. B. Bennett, “Pain Management for Sickle Cell Disease in Children and Adults,” Cochrane Database of Systematic Reviews, No. 2. 2006, Article ID: CD003350. doi:10.1002/14651858.CD003350.pub2
[4] J. Glassberg, “Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I (RESCUED),” 2012. http://clinicaltrials.gov/ct2/show/NCT01256281
[5] P. G. Firth, C. A. Head and D. C. David, “Sickle Cell Disease and Anesthesia,” Anesthesiology, Vol. 101, No. 3, 2004, pp. 766-785.
[6] C. B. Berde and F. S. Navil, “Analgesics for the Treatment of Pain in Children,” The New England Journal of Medicine, Vol. 347, No. 14, 2002, 1094-1103.
[7] M. Yaster, R. T. Joseph, B. Carol, F. C. James and D. George, “Epidural Analgesia in the Management of Severe Vaso-Occlusive Sickle Cell Crisis,” Pediatrics, Vol. 93, No. 2, 1994, pp. 310-315